PL2121025T3 - Sposoby i kompozycje dla dostarczania czynnika terapeutycznego - Google Patents
Sposoby i kompozycje dla dostarczania czynnika terapeutycznegoInfo
- Publication number
- PL2121025T3 PL2121025T3 PL08705994T PL08705994T PL2121025T3 PL 2121025 T3 PL2121025 T3 PL 2121025T3 PL 08705994 T PL08705994 T PL 08705994T PL 08705994 T PL08705994 T PL 08705994T PL 2121025 T3 PL2121025 T3 PL 2121025T3
- Authority
- PL
- Poland
- Prior art keywords
- delivery
- compositions
- methods
- therapeutic agent
- therapeutic
- Prior art date
Links
- 239000003814 drug Substances 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 229940124597 therapeutic agent Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
- A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
- A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
- A61K31/5517—1,4-Benzodiazepines, e.g. diazepam or clozapine condensed with five-membered rings having nitrogen as a ring hetero atom, e.g. imidazobenzodiazepines, triazolam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0031—Rectum, anus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Otolaryngology (AREA)
- Psychiatry (AREA)
- Dispersion Chemistry (AREA)
- Pulmonology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Pain & Pain Management (AREA)
- Anesthesiology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IS8593 | 2007-01-19 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2121025T3 true PL2121025T3 (pl) | 2017-09-29 |
Family
ID=39512543
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL08705994T PL2121025T3 (pl) | 2007-01-19 | 2008-01-18 | Sposoby i kompozycje dla dostarczania czynnika terapeutycznego |
Country Status (11)
| Country | Link |
|---|---|
| EP (2) | EP2121025B1 (enExample) |
| JP (5) | JP5877939B2 (enExample) |
| CN (3) | CN106389330A (enExample) |
| AU (1) | AU2008206105B2 (enExample) |
| CA (1) | CA2676010C (enExample) |
| DK (1) | DK2121025T3 (enExample) |
| ES (1) | ES2611995T3 (enExample) |
| HU (1) | HUE031463T2 (enExample) |
| IL (1) | IL199904A (enExample) |
| PL (1) | PL2121025T3 (enExample) |
| WO (1) | WO2008089426A2 (enExample) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0720716D0 (en) * | 2007-10-23 | 2007-12-05 | York Pharma Plc | Novel formulation |
| GB2481407B (en) * | 2010-06-22 | 2012-05-23 | Special Products Ltd | A rapid onset liquid midazolam composition for buccal administration |
| SMT201800105T1 (it) * | 2011-05-13 | 2018-05-02 | Euro Celtique Sa | Forme posologiche farmaceutiche intranasali comprendenti naloxone |
| EP3681474B1 (en) * | 2017-09-11 | 2025-10-29 | Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. | Compositions and methods for nasal administration of drugs to brain and for systemic effect |
| JP2019099557A (ja) * | 2017-11-28 | 2019-06-24 | 日本化薬株式会社 | ベンダムスチンを含有する溶液製剤 |
| WO2019226753A1 (en) | 2018-05-25 | 2019-11-28 | Ucb Biopharma Sprl | Benzodiazepine formulations |
| CN111388481A (zh) * | 2020-03-20 | 2020-07-10 | 浙江美华鼎昌医药科技有限公司 | 一种咪达唑仑和丙戊酸钠的药物组合物及其制备方法 |
| CN114588116B (zh) * | 2020-12-04 | 2024-03-15 | 四川科瑞德制药股份有限公司 | 磷苯妥英钠固体组合物、冻干方法、及其用途 |
| CN113274482B (zh) * | 2021-06-07 | 2023-09-05 | 穆琳 | 缩宫素或其衍生物在制备治疗或改善贫乳的制剂中的用途以及组合物 |
| WO2024142091A1 (en) * | 2022-12-26 | 2024-07-04 | Cipla Limited | Stable aqueous injectable formulation of flucytosine |
| WO2025115019A1 (en) * | 2023-11-30 | 2025-06-05 | Padagis Israel Pharmaceuticals Ltd. | Stable nitroglycerin formulations |
Family Cites Families (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4153689A (en) | 1975-06-13 | 1979-05-08 | Takeda Chemical Industries, Ltd. | Stable insulin preparation for nasal administration |
| WO1987005210A1 (fr) * | 1986-03-10 | 1987-09-11 | Kurt Burghart | Produit pharmaceutique et son procede de preparation |
| US4782047A (en) | 1986-05-22 | 1988-11-01 | Syntex Pharmaceuticals International Ltd. | Aqueous steroid formulations for nasal administration |
| DE3734306A1 (de) | 1987-10-10 | 1989-04-27 | Pfeiffer Erich Gmbh & Co Kg | Austragvorrichtung fuer fliessfaehige medien |
| EP0532546B1 (en) | 1990-05-10 | 1998-03-18 | Bechgaard International Research And Development A/S | A pharmaceutical preparation containing n-glycofurols and n-ethylene glycols |
| US5338732A (en) * | 1991-06-18 | 1994-08-16 | Bristol-Myers Squibb Company | Megestrol acetate formulation |
| GB9125699D0 (en) | 1991-12-03 | 1992-01-29 | Glaxo Group Ltd | Device |
| US5897880A (en) * | 1995-09-29 | 1999-04-27 | Lam Pharmaceuticals, Llc. | Topical drug preparations |
| HUP9903942A3 (en) * | 1996-07-03 | 2000-07-28 | Alza Corp | Non-aqueous protic peptide formulations |
| CA2379365C (en) * | 1999-07-26 | 2009-11-17 | Sk Corporation | Transnasal anticonvulsive compositions and modulated process |
| KR100360827B1 (ko) * | 1999-08-14 | 2002-11-18 | 주식회사 삼양사 | 난용성 약물을 가용화하기 위한 고분자 조성물 및 그의 제조방법 |
| KR100345214B1 (ko) * | 1999-08-17 | 2002-07-25 | 이강춘 | 생체적합성 고분자가 수식된 펩타이드의 비점막 전달 |
| DE19940236A1 (de) | 1999-08-25 | 2001-03-08 | Pfeiffer Erich Gmbh & Co Kg | Spender mit manuell betätigbarer Ausbringeinrichtung |
| US20020037319A1 (en) * | 1999-11-08 | 2002-03-28 | Alan Drizen | Drug preparations |
| US6610271B2 (en) * | 2000-05-10 | 2003-08-26 | University Of Kentucky Research Foundation | System and method for intranasal administration of lorazepam |
| US6948492B2 (en) | 2000-08-15 | 2005-09-27 | University Of Kentucky Research Foundation | Programmable multi-dose intranasal drug delivery device |
| WO2003099264A1 (en) * | 2002-05-23 | 2003-12-04 | Umd, Inc. | Compositions and method for transmucosal drug delivery and cryoprotection |
| JP4542743B2 (ja) * | 2002-12-26 | 2010-09-15 | Ｋｄｌ株式会社 | ピリドン誘導体の溶液状医薬組成物 |
| JP2007070225A (ja) * | 2003-07-25 | 2007-03-22 | Yukako Fujinaga | クロストリジウム属菌由来成分を含む医薬製剤 |
| WO2005027977A2 (en) * | 2003-09-22 | 2005-03-31 | Agis Industries (1983) Ltd. | Diclofenac compositions for the treatment of skin disorders |
| US20050244517A1 (en) * | 2003-11-05 | 2005-11-03 | Santarus, Inc. | Combination of proton pump inhibitor and sleep aid |
| GB0400804D0 (en) * | 2004-01-14 | 2004-02-18 | Innoscience Technology Bv | Pharmaceutical compositions |
| JP4746856B2 (ja) * | 2004-08-12 | 2011-08-10 | 三笠製薬株式会社 | ピラゾロン系製剤 |
| US20060110415A1 (en) * | 2004-11-22 | 2006-05-25 | Bioderm Research | Topical Delivery System for Cosmetic and Pharmaceutical Agents |
| EP1848403B8 (en) * | 2005-01-14 | 2010-05-19 | Camurus Ab | Topical bioadhesive formulations |
| US20070021411A1 (en) * | 2005-05-11 | 2007-01-25 | Cloyd James C | Supersaturated benzodiazepine solutions and their delivery |
| TW200824693A (en) * | 2006-08-28 | 2008-06-16 | Jazz Pharmaceuticals Inc | Pharmaceutical compositions of clonazepam and methods of use thereof |
| KR20090087079A (ko) * | 2006-11-21 | 2009-08-14 | 노파르티스 아게 | 벤조디아제핀 구조의 ｒｓｖ 억제제를 포함하는 안정한 비경구 제형 |
-
2008
- 2008-01-18 AU AU2008206105A patent/AU2008206105B2/en active Active
- 2008-01-18 CA CA2676010A patent/CA2676010C/en active Active
- 2008-01-18 EP EP08705994.5A patent/EP2121025B1/en active Active
- 2008-01-18 CN CN201610672083.8A patent/CN106389330A/zh active Pending
- 2008-01-18 PL PL08705994T patent/PL2121025T3/pl unknown
- 2008-01-18 JP JP2009546547A patent/JP5877939B2/ja active Active
- 2008-01-18 WO PCT/US2008/051466 patent/WO2008089426A2/en not_active Ceased
- 2008-01-18 HU HUE08705994A patent/HUE031463T2/en unknown
- 2008-01-18 DK DK08705994.5T patent/DK2121025T3/en active
- 2008-01-18 CN CN201610674407.1A patent/CN106420614A/zh active Pending
- 2008-01-18 ES ES08705994.5T patent/ES2611995T3/es active Active
- 2008-01-18 EP EP16195222.1A patent/EP3150230A1/en not_active Withdrawn
- 2008-01-18 CN CN200880005593.3A patent/CN101678112B/zh active Active
-
2009
- 2009-07-16 IL IL199904A patent/IL199904A/en not_active IP Right Cessation
-
2013
- 2013-08-19 JP JP2013169582A patent/JP2013231089A/ja active Pending
-
2015
- 2015-11-27 JP JP2015231350A patent/JP6084277B2/ja active Active
-
2016
- 2016-12-08 JP JP2016238150A patent/JP6295314B2/ja active Active
-
2017
- 2017-06-15 JP JP2017117506A patent/JP2017155060A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| HUE031463T2 (en) | 2017-07-28 |
| DK2121025T3 (en) | 2017-01-30 |
| CN101678112B (zh) | 2016-08-31 |
| AU2008206105A1 (en) | 2008-07-24 |
| ES2611995T3 (es) | 2017-05-11 |
| JP2017048250A (ja) | 2017-03-09 |
| JP2016029117A (ja) | 2016-03-03 |
| CN106420614A (zh) | 2017-02-22 |
| JP2013231089A (ja) | 2013-11-14 |
| CA2676010A1 (en) | 2008-07-24 |
| EP2121025B1 (en) | 2016-11-02 |
| JP5877939B2 (ja) | 2016-03-08 |
| WO2008089426A2 (en) | 2008-07-24 |
| EP3150230A1 (en) | 2017-04-05 |
| JP6295314B2 (ja) | 2018-03-14 |
| CN106389330A (zh) | 2017-02-15 |
| JP2017155060A (ja) | 2017-09-07 |
| IL199904A (en) | 2014-07-31 |
| JP2010516696A (ja) | 2010-05-20 |
| JP6084277B2 (ja) | 2017-02-22 |
| CN101678112A (zh) | 2010-03-24 |
| AU2008206105B2 (en) | 2014-04-03 |
| EP2121025A2 (en) | 2009-11-25 |
| CA2676010C (en) | 2016-05-17 |
| WO2008089426A3 (en) | 2009-02-12 |
| IL199904A0 (en) | 2010-04-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL2121025T3 (pl) | Sposoby i kompozycje dla dostarczania czynnika terapeutycznego | |
| AP2965A (en) | Therapeutic compositions and the use thereof | |
| AP2490A (en) | Therapeutic compositions and the use thereof | |
| EP2242527A4 (en) | DEVICES AND METHODS FOR ADMINISTERING A THERAPEUTIC AGENT THROUGH PNEUMOSTOMY | |
| ZA200904935B (en) | Benefit agent delivery compositions | |
| IL202684A0 (en) | Anti-cd20 therapeutic compositions and methods of use thereof | |
| EP2180873A4 (en) | THERAPEUTIC DENTAL COMPOSITION AND RELATED METHODS | |
| IL207569A0 (en) | Compositions and methods for drug delivery | |
| EP2046430A4 (en) | ADMINISTRATION OF ANTI-THERAPY | |
| EP2101855A4 (en) | ADMINISTRATION OF ANTI-THERAPY | |
| GB0625659D0 (en) | Therapeutic compounds and their use | |
| GB0609492D0 (en) | Therapeutic agents | |
| GB0608928D0 (en) | Therapeutic agents | |
| GB0601962D0 (en) | Therapeutic agents | |
| IL195764A0 (en) | Compositions and methods for drug delivery | |
| EP2010162A4 (en) | COMPOSITION FOR DISPOSING A MEDICINAL PRODUCT | |
| IL198723A0 (en) | Methods and compositions for therapeutic treatment | |
| IL197235A0 (en) | Therapeutic compositions | |
| GB0616214D0 (en) | Therapeutic Agents | |
| ZA200807486B (en) | Medicament formulations comprising fluoroquinolones | |
| PL2012805T3 (pl) | Kompozycja lecznicza i jej zastosowanie | |
| EP2236148A4 (en) | MEDIinic agent for HELICOBACTER treatment | |
| GB0611152D0 (en) | Therapeutic agents | |
| EP2236145A4 (en) | PHARMACEUTICAL COMPOSITION AND ACTIVE INGREDIENT COMBINATION | |
| EP2231163A4 (en) | COMPOUNDS AND THEIR THERAPEUTIC USE |